Genomics as a Clinical Decision Support Tool: Successful Proof of Concept for Improved ASD Outcomes
Considerable evidence is emerging that Autism Spectrum Disorder (ASD) is most often triggered by a range of different genetic variants that interact with environmental factors such as exposures to toxicants and changes to the food supply. Up to 80% of genetic variations that contribute to ASD found...
Main Authors: | Heather Way, Grant Williams, Sharon Hausman-Cohen, Jordan Reeder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/7/596 |
Similar Items
-
The issue of prevalence of autism/asd
by: Kamil Özerk
Published: (2016-12-01) -
The Issue of Prevalence of Autism/ASD
by: Kamil ÖZERK
Published: (2016-12-01) -
Utilizing Genomically Targeted Molecular Data to Improve Patient-Specific Outcomes in Autism Spectrum Disorder
by: Sharon Hausman-Cohen, et al.
Published: (2022-02-01) -
Neurodevelopmental problems and extremes in BMI
by: Nóra Kerekes, et al.
Published: (2015-07-01) -
Trait-Based Dimensions Discriminating Adults with Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD) and, Co-occurring ADHD/ASD
by: Artemios Pehlivanidis, et al.
Published: (2020-12-01)